Cargando…
Alexithymia Has No Clinically Relevant Association With Outcome of Multimodal Treatment Tailored to Needs of Patients Suffering From Somatic Symptom and Related Disorders. A Clinical Prospective Study
Introduction: Alexithymia may moderate the effectiveness of treatment and may predict impaired general functioning of patients suffering from somatic symptom and related disorders (SSRD). Aim: We compared alexithymia levels in a clinical prospective study with 234 consecutive patients suffering from...
Autores principales: | de Vroege, Lars, Emons, Wilco H. M., Sijtsma, Klaas, van der Feltz-Cornelis, Christina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066688/ https://www.ncbi.nlm.nih.gov/pubmed/30087625 http://dx.doi.org/10.3389/fpsyt.2018.00292 |
Ejemplares similares
-
Psychometric Properties of the Bermond–Vorst Alexithymia Questionnaire (BVAQ) in the General Population and a Clinical Population
por: de Vroege, Lars, et al.
Publicado: (2018) -
Alexithymia and Psychopathology in Patients Suffering From Inflammatory Bowel Disease: Arising Differences and Correlations to Tailoring Therapeutic Strategies
por: Viganò, Caterina A., et al.
Publicado: (2018) -
Comparison of the Factor Structure of the Patient Health Questionnaire for Somatic Symptoms (PHQ-15) in Germany, the Netherlands, and China. A Transcultural Structural Equation Modeling (SEM) Study
por: Leonhart, Rainer, et al.
Publicado: (2018) -
Type D Personality, Concomitant Depressive and Anxiety Disorders, and Treatment Outcomes in Somatic Symptom and Related Disorders: An Observational Longitudinal Cohort Study
por: de Vroege, Lars, et al.
Publicado: (2019) -
Validation of the PHQ-15 for Somatoform Disorder in the Occupational Health Care Setting
por: de Vroege, Lars, et al.
Publicado: (2011)